Pharma-Bio Serv (PBSV) Interest Expenses (2010 - 2013)

Pharma-Bio Serv's Interest Expenses history runs 4 years deep, the most recent figure standing at $1903.0 for Q2 2013.

• Interest Expenses for Q2 2013 came in at $1903.0, down 8.55% year-over-year; the trailing twelve-month figure through Jan 2014 was $1903.0 (down 73.85% YoY), and the FY2013 annual result was $7213.0, down 2.86% from the prior year.
• Interest Expenses came in at $1903.0 for Q2 2013 at Pharma-Bio Serv, down from $2100.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2575.0 in Q3 2011 to a low of $689.0 in Q4 2011.
• A 4-year average of $1745.1 and a median of $1909.0 in 2012 frame the typical range for Interest Expenses.
• The largest YoY upside for Interest Expenses was 72.01% in 2011 against a maximum downside of 51.17% in 2011.
• Over 4 years, Interest Expenses stood at $1411.0 in 2010, then plunged by 51.17% to $689.0 in 2011, then soared by 71.55% to $1182.0 in 2012, then surged by 61.0% to $1903.0 in 2013.
• The last three Interest Expenses figures came in at $1903.0 (Q2 2013), $2100.0 (Q1 2013), and $1182.0 (Q4 2012), per Business Quant data.